关注
Shazreh Bukhari
Shazreh Bukhari
Medical Student
在 kansascity.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia
JM Gawel, AE Shouksmith, YS Raouf, N Nawar, K Toutah, S Bukhari, ...
European Journal of Medicinal Chemistry 201, 112411, 2020
402020
ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts
AL Yuan, CB Ricks, AK Bohm, X Lun, L Maxwell, S Safdar, S Bukhari, ...
PLoS One 13 (8), e0202860, 2018
322018
Development of HDAC inhibitors exhibiting therapeutic potential in T-cell prolymphocytic leukemia
K Toutah, N Nawar, S Timonen, H Sorger, YS Raouf, S Bukhari, J von Jan, ...
Journal of medicinal chemistry 64 (12), 8486-8509, 2021
292021
Class I/IIb-selective HDAC inhibitor exhibits oral bioavailability and therapeutic efficacy in acute myeloid leukemia
AE Shouksmith, JM Gawel, N Nawar, D Sina, YS Raouf, S Bukhari, L He, ...
ACS Medicinal Chemistry Letters 11 (1), 56-64, 2019
262019
Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma
N Nawar, S Bukhari, AA Adile, Y Suk, P Manaswiyoungkul, K Toutah, ...
Journal of medicinal chemistry 65 (4), 3193-3217, 2022
202022
Unique molecular interaction with the histone deacetylase 6 catalytic tunnel: crystallographic and biological characterization of a model chemotype
OO Olaoye, PR Watson, N Nawar, M Geletu, A Sedighi, S Bukhari, ...
Journal of medicinal chemistry 64 (5), 2691-2704, 2021
182021
In vitro modeling of glioblastoma initiation using PDGF-AA and p53-null neural progenitors
AK Bohm, J DePetro, CE Binding, A Gerber, N Chahley, ND Berger, ...
Neuro-oncology 22 (8), 1150-1161, 2020
132020
High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lym
HK Garcha, N Nawar, H Sorger, F Erdogan, MMK Aung, A Sedighi, ...
Pharmaceutics 15 (11)), 2022
2022
Characterization and Biological Evaluation of HDAC6 Selective Inhibitors
S Bukhari
University of Toronto (Canada), 2020
2020
Beyond Conventional Models: Recreating the Initiation, Evolution, and Genome of GBM
A Bohm, J DePetro, C Binding, A Gerber, N Chahley, M Ware, K Thomas, ...
bioRxiv, 837138, 2019
2019
TMOD-02. A MODEL OF THE INITIATION AND GENOMIC LANDSCAPE OF GLIOBLASTOMA (GBM)
A Bohm, J DePetro, C Binding, C Grisdale, M Ware, S Lawn, N Chahley, ...
Neuro-Oncology 21 (Suppl 6), vi262, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–11